Heart rate variability: for real doctors. Translation from the Russian version of the book, published at Kharkiv, 2010, 131 p.
The basics and practice of the clinical use of the technology of heart rate variability are outlined for doctors of all specialties and students of medical faculties of universities.
9. Regulation in the disease
Regulation and patient management
In the management of the patient, any intervention, from instrumental and pharmacotherapeutic, to physiotherapeutic and balneological, should, if not affect the pathological process, have a positive effect on the dynamics of regulatory processes, then at least not exacerbate it.
The remark is especially crucial for persons with severe deviations of regulatory systems and processes from physiological standards when there is a threat of catastrophe.
The individuality of a person, his regulatory systems, realized in the identity of health and personality of the course of the disease, presupposes character of reactions, and to the implemented medical interventions.
“Treat the patient, but not the disease” is a concentrated expression of the understanding of this exclusivity of the person and concerning the medical management.
HRV technology allows you to plan, monitor, and edit medical interventions for regulatory systems.
Lifestyle, exercise, and professional activities should be adjusted in such a way that regulatory systems are maintained.
In this regard, we refer the reader to the previous chapter, where the impact of physical and mental stress, modulated breathing and music of different tempos on the overall power of the spectrum and the structure of HRV as characteristics of quality and reserves of regulation was considered in detail. Drugs that directly affect regulatory systems are also known. For example, increase the power of HRV spectrum scopolamine and beta-blockers.